{"anticipatedPostingDate":"2027-06","denomUnitsSelected":"Participants","description":"Serum samples collected for the analysis of the presence of ADAs using validated immunoassays. All samples will be to be further tested in screening assay, and positive samples will be further to be characterized for antibody titers.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 73 months","title":"Titers of ADAs Against Belantamab Mafodotin","type":"SECONDARY"}